This Article Full Text Full Text (PDF) All Versions of this Article: 106/2/227    most recent 01.CIR.0000021601.49664.2Av1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wachtell, K. Articles by Devereux, R. B. Search for Related Content PubMed PubMed Citation Articles by Wachtell, K. Articles by Devereux, R. B. Related Collections Contractile function Secondary prevention Hypertrophy Clinical Studies

(Circulation. 2002;106:227.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment

The Losartan Intervention for Endpoint (LIFE) Study

Kristian Wachtell, MD, PhD; Vittorio Palmieri, MD; Michael H. Olsen, MD, PhD; Eva Gerdts, MD, PhD; Vasilios Papademetriou, MD; Markku S. Nieminen, MD; Gunnar Smith, MD; Björn Dahlöf, MD, PhD; Gerard P. Aurigemma, MD; Richard B. Devereux, MD

From the Copenhagen County University Hospital (K.W., M.H.O.), Glostrup, Denmark; Weill Medical College of Cornell University (K.W., V. Palmieri, R.B.D.), New York, NY; Haukeland Hospital (E.G.), Bergen, Norway; VA Medical Center (V. Papademetriou), Washington, DC; Helsinki University Central Hospital (M.S.N.), Helsinki, Finland; Ullevål University Hospital (G.S.), Oslo, Norway; University of Massachusetts Medical Center (G.P.A.), Worcester, Mass; and Sahlgrenska University Hospital-Östra (B.D.), Göteborg, Sweden.

Correspondence to Dr Kristian Wachtell, Laboratory of Cardiology, Department of Medicine, Copenhagen County University Hospital, Glostrup, DK-2600 Glostrup, Denmark. E-mail kristian{at}wachtell.net

Background— We have shown that hypertensive patients with left ventricular (LV) hypertrophy have decreased LV midwall mechanics, but the effect of antihypertensive therapy remains unclear.

Methods and Results— Echocardiograms were recorded at baseline in 679 hypertensive patients and ECG LV hypertrophy and repeated yearly during 3 years of blinded treatment to achieve target blood pressures (BPs) of 140/90 mm Hg. On average, BP was reduced from 174±21 to 147±19 over 95±11 to 82±10 mm Hg and LV mass from 234±56 to 194±50 g. Endocardial fractional shortening (FS) decreased slightly, whereas midwall FS increased from 15.4±2.0% to 16.8±2.1% and stress-corrected midwall FS increased from 97±13 to 105±12% (all P<0.001). Change in midwall FS was related inversely to change in LV mass (LVM), relative wall thickness (RWT), and diastolic BP and directly to change in Doppler stroke volume (SV, all P<0.001). Multivariate analysis showed that change in MWS was independently inversely related to changes in LVM (ß=-0.211), RWT (ß=-0.334, all P<0.001), and diastolic BP (ß=-0.088, P<0.05) and directly related to SV (ß=0.192, P<0.001) with control for blinded therapy. Change in stress-corrected midwall shortening was inversely independently associated with changes in LVM (ß=-0.153) and RWT (ß=-0.562) and directly with changes in SV (ß=0.145) and systolic BP (ß=0.s221, all P<0.001) with control for blinded therapy.

Conclusions— Antihypertensive therapy reduced LVM and increased LV midwall shortening and contractility with a small decrease in LV chamber function and significant increase in SV. Change in systolic LV performance was independently associated inversely with change in LVM, RWT, and BP and directly with change in SV.

Key Words: echocardiography • electrocardiography • hypertrophy • heart failure • hypertension

This article has been cited by other articles:

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients Ann Intern Med, September 4, 2007; 147(5): 311 - 319. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, B. Dahlof, and for the LIFE Study Investigators Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Circulation, January 3, 2006; 113(1): 67 - 73. [Abstract] [Full Text] [PDF]

				K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16. [Abstract] [Full Text] [PDF]

				M. H. Drazner, J. E. Rame, E. K. Marino, J. S. Gottdiener, D. W. Kitzman, J. M. Gardin, T. A. Manolio, D. L. Dries, and D. S. Siscovick Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: The Cardiovascular Health Study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2207 - 2215. [Abstract] [Full Text] [PDF]

				E. M. Escudero, M. C. C. d. Hurtado, N. G. Perez, and A. L. Tufare Echocardiographic assessment of left ventricular midwall mechanics in spontaneously hypertensive rats Eur J Echocardiogr, June 1, 2004; 5(3): 169 - 175. [Abstract] [Full Text] [PDF]

				O. H. Cingolani, X.-P. Yang, Y.-H. Liu, M. Villanueva, N.-E. Rhaleb, and O. A. Carretero Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats Hypertension, May 1, 2004; 43(5): 1067 - 1073. [Abstract] [Full Text] [PDF]